More
    Guided Solutions - Connecting Talent With Innovation/div>

    Microbot Medical to raise over $92M from stock sale

    Microbot Medical said investors agreed to exercise outstanding preferred investment options that could generate up to $92.2 million in gross proceeds. The company expects about...

    SafeHeal raises €10M Series C extension for colorectal surgery device

    Paris-based MedTech startup SafeHeal secured a €10 million extension to its Series C funding round. Asabys Partners, via its Sabadell Asabys II fund, led...

    Ronovo Surgical raises $67M for surgical robot, signs J&J collaboration

    Ronovo Surgical announced today that it closed its Series D financing round with a total investment of $67 million. Johnson & Johnson’s corporate venture capital...

    Boomerang Medical raises $20M for sacral neuromod tech for inflammatory bowel disease

    Boomerang Medical announced today that it raised $20 million in a Series B financing to support its implantable neuromodulation system. The women-led bioelectronic medicine company...

    Galvanize Therapeutics closes $100m Series C financing, hires new CEO

    Galvanize Therapeutics announced it raised $100 million and appointed Doug Godshall as chair and CEO. Godshall previously served as CEO of HeartWare before its $1...

    ViCentra raises $85m to drive insulin pump’s US market entry

    Dutch device company ViCentra has raised $85m to boost its Kaleido insulin patch pump’s entry onto the US market. According to the company, initial commercial...

    Berlin Heals Holding raises over $5m to advance heart failure treatment

    Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to reverse remodel and recover from Heart Failure. After a successful First-In-Human...

    Cyted raises $44m to propel US market expansion of its endoscopic capsule

    UK-based Cyted Health has raised $44m to accelerate the ongoing market adoption of its EndoSign device in the US. The gastrointestinal (GI) diagnostic company’s EndoSign...

    SynCardia parent prices $17M IPO to support next-gen artificial heart

    Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced the pricing of a $17 million initial public offering (IPO). The Tucson, Arizona–based...

    Latest articles